Accessibility Menu
 
Cardio Diagnostics logo

Cardio Diagnostics

(NASDAQ) CDIO

Current Price$2.15
Market Cap$6.66M
Since IPO (2022)-99%
5 YearN/A
1 Year-83%
1 Month-22%

Cardio Diagnostics Financials at a Glance

Market Cap

$6.66M

Revenue (TTM)

$14.82K

Net Income (TTM)

$6.50M

EPS (TTM)

$-3.72

P/E Ratio

-0.61

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$2.15

Volume

1,335

Open

$2.15

Previous Close

$2.15

Daily Range

$2.12 - $2.22

52-Week Range

$0.97 - $17.39

CDIO News

No articles available.

CDIO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardio Diagnostics

Industry

Biotechnology

Employees

15

CEO

Meeshanthini V. Dogan, PhD

Headquarters

Chicago, IL 60642, US

CDIO Financials

Key Financial Metrics (TTM)

Gross Margin

-22%

Operating Margin

-437%

Net Income Margin

-438%

Return on Equity

-79%

Return on Capital

-91%

Return on Assets

-84%

Earnings Yield

-1.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.66M

Shares Outstanding

2.96M

Volume

1.33K

Short Interest

0.00%

Avg. Volume

4.12M

Financials (TTM)

Gross Profit

$383.30K

Operating Income

$6.48M

EBITDA

$6.09M

Operating Cash Flow

$5.73M

Capital Expenditure

$187.32K

Free Cash Flow

$5.91M

Cash & ST Invst.

$5.11M

Total Debt

$695.62K

Cardio Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.56K

-21.2%

Gross Profit

$155.75K

-3552.0%

Gross Margin

-43.81%

N/A

Market Cap

$6.66M

N/A

Market Cap/Employee

$512.22K

N/A

Employees

13

N/A

Net Income

$1.47M

+3.6%

EBITDA

$1.37M

+4.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.42M

-35.6%

Accounts Receivable

$8.13K

-56.3%

Inventory

$0.00

N/A

Long Term Debt

$188.22K

-55.8%

Short Term Debt

$507.40K

-6.7%

Return on Assets

-83.67%

N/A

Return on Invested Capital

-90.54%

N/A

Free Cash Flow

$1.38M

+1.2%

Operating Cash Flow

$1.36M

+2.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCDABioCardia, Inc.
$1.21+0.42%
TCRTAlaunos Therapeutics, Inc.
$3.14-1.88%
IBOImpact BioMedical Inc.
$0.62-4.14%
RADXRadiopharm Theranostics Limited
$4.14-10.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$175.20-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.62-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%

Questions About CDIO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.